Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Latest Articles

  • You have access
    MAP17 as a Mediator of HGF-induced Proliferation and Invasion in Gastric Cancer
    BYEONG IL JANG, JI YOON JUNG, SUNG AE KOH, YONG-EUN PARK and KYUNG HEE LEE
    Anticancer Research May 2025, 45 (5) 2011-2024; DOI: https://doi.org/10.21873/anticanres.17576
  • You have access
    Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
    MASANORI AOKI, HIROSHI MATSUI, SOTA KURIHARA, NOBUAKI OHTAKE, SHUN NAKAZAWA, YUSUKE TSUJI, YUJI FUJIZUKA, SEIJI ARAI, MASASHI NOMURA, YOSHITAKA SEKINE, HIDEKAZU KOIKE, KAZUHIRO SUZUKI and YOSHIYUKI MIYAZAWA
    Anticancer Research May 2025, 45 (5) 2195-2204; DOI: https://doi.org/10.21873/anticanres.17593
  • You have access
    Potential Role of PTEN and AKT/PKB Proteins in the Pathogenesis of Ovarian Mature Teratomas
    JAROSŁAW BAL, LUKASZ FULAWKA, MARIAN GABRYŚ, MAREK MURAWSKI and AGNIESZKA HALON
    Anticancer Research May 2025, 45 (5) 1843-1851; DOI: https://doi.org/10.21873/anticanres.17563
  • Open Access
    Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan
    CHAO-HSUAN CHEN, CHUN-CHUNG CHEN, XIAN-XIU CHEN, WEN-SHIN CHANG, CHIA-WEN TSAI, MEI-CHIN MONG, SHIH-WEI HSU and DA-TIAN BAU
    Anticancer Research May 2025, 45 (5) 1861-1870; DOI: https://doi.org/10.21873/anticanres.17565
  • Open Access
    Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis
    JAN LEPPERT, CLAUDIA DITZ, JAKOB MATSCHKE, HARALD KRENZLIN, NAUREEN KERIC, CHRISTIAN ZIEMANN, LORENZ HAHN, MARIA VITTORIA MATONE, LARYSA LIUBICH, KAROLIN STREUBEL, HANNES SCHACHT, CHRISTINA HILLBRICHT, PATRICK KUPPLER, DIRK RADES and ANASTASSIA LÖSER
    Anticancer Research May 2025, 45 (5) 2059-2069; DOI: https://doi.org/10.21873/anticanres.17580
  • Open Access
    Chemotherapy-induced Moderate to Severe Peripheral Neuropathy in Patients Receiving Adjuvant Radiotherapy for Breast Cancer
    DIRK RADES, TOBIAS BARTSCHT, ACHIM RODY, NATHAN Y. YU and MARTIN BALLEGAARD
    Anticancer Research May 2025, 45 (5) 2123-2135; DOI: https://doi.org/10.21873/anticanres.17587
  • You have access
    The Long-term Outcomes of Borderline Resectable T3 in Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Triplet Chemotherapy
    JUNYA KITADANI, KEIJI HAYATA, TARO GODA, SHINTA TOMINAGA, NAOKI FUKUDA, TOMOKI NAKAI, SHOTARO NAGANO and MANABU KAWAI
    Anticancer Research May 2025, 45 (5) 2225-2235; DOI: https://doi.org/10.21873/anticanres.17596
  • Open Access
    Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal Fibroblasts
    YOHEI ASANO, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, JIN SOO KIM, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research May 2025, 45 (5) 1871-1876; DOI: https://doi.org/10.21873/anticanres.17566
  • You have access
    Correlation Analysis Between IFIT2 and HLA Class II in Oral Cancer
    KUO-CHU LAI, CHI-WEI CHEN, PETER MU-HSIN CHANG, YI-CHUN LIAO, CHUANG-WEI WANG, CHIA-HSUN HSIEH and TSUNG-TENG HUANG
    Anticancer Research May 2025, 45 (5) 1897-1914; DOI: https://doi.org/10.21873/anticanres.17568
  • You have access
    HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling
    GHALEB ELYAMANY, SULTAN ALOTAIBI, BANDER ALHARBI, OSAMA ATALLAH ALHAFI, HASSAN ALJASEM, HADI JAMIL, TARIQ M. ROSHAN, ARIZ AKHTER and ADNAN MANSOOR
    Anticancer Research May 2025, 45 (5) 2079-2089; DOI: https://doi.org/10.21873/anticanres.17582

Pages

  • Previous
  • Next
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 1739
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire